Proteostasis Therapeutics To Use $37 Million in New Funding For Novel Cystic Fibrosis Therapy
Cystic Fibrosis, News
Yesterday, Proteostasis Therapeutics, Inc. (PTI) announced it had raised $37 million in new funding that will be used to develop its lead product candidate for the treatment of cystic fibrosis (CF) in human ... Read more